UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Hepatitis C virus (HCV)-specific T cell confer resistance to HCV re-infection after sustained virologic response in a non-cytolytic fashion among people who inject drugs: results from ANCHOR study

Journal of hepatology, 2022-07, Vol.77, p.S571

2022

Volltextzugriff (PDF)

Long-term outcomes associated with task-shifting of HCV treatment by non-specialist providers: five year follow-up from the ASCEND cohort

Journal of hepatology, 2022-07, Vol.77, p.S574

2022

Volltextzugriff (PDF)

Diabetes Mellitus Type II and Abnormal Glucose Metabolism in the setting of HIV

Endocrinology and metabolism clinics of North America, 2014-09, Vol.43 (3), p.685-696

2014

Volltextzugriff (PDF)

Association of sustained virologic response with measures of direct-acting antiviral adherence in patients with Hepatitis C: data from the ASCEND and ANCHOR investigations

Journal of hepatology, 2022-07, Vol.77, p.S552

2022

Volltextzugriff (PDF)

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus: HIV and Endocrine Disorders

Endocrinology and metabolism clinics of North America, 2014, Vol.43 (3)

2014

Volltextzugriff (PDF)

Expansion of Treatment for Hepatitis C Virus Infection

Annals of internal medicine, 2018-03, Vol.168 (6), p.457

2018

Volltextzugriff (PDF)

HCV reinfection associated with IDU and cocaine use in a cohort of people with OUD: 4 Year follow-up data from the ANCHOR cohort

Journal of hepatology, 2022-07, Vol.77, p.S572

2022

Volltextzugriff (PDF)

100. "They Never Asked Me": A Mixed-Methods Study to Evaluate the INJECT-RESPECT Tool for Assessing Infectious and Non-Infectious risks of Injection Drug Use

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial

Annals of internal medicine, 2015-12, Vol.163 (12), p.899

2015

Volltextzugriff (PDF)

Use of Non-Stigmatizing Language is Associated with Improved Outcomes in Hospitalized People Who Inject Drugs

Journal of hospital medicine, 2023-06, Vol.18 (8), p.670-676

2023

Volltextzugriff (PDF)

298. Collocation of Hepatitis C Care Continuum with MAT for High-Prevalence, High-Risk Population

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S161-S161

2019

Volltextzugriff (PDF)

2061. High Rates of Viremic HIV, Risky Sexual Behaviors, and Interest in Gender Affirming Hormone Therapy among Transgender Individuals Who Engage in Transactional Sex

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

799. Unstable Housing, Daily Drug Use, and Transactional Sex are Associated with Viremia in Transgender Individuals Living with HIV

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

1362. Adding Insult to Injury: Association of Stigmatizing Language and Suboptimal Outcomes in People Who Inject Drugs

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S767-S768

2021

Volltextzugriff (PDF)

611. No Source Control: Low Rates of Medication for Opioid Use Disorder in Individuals Hospitalized with Infectious Complications of Injection Opioid Use at Four Academic Medical Centers

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S408-S409

2021

Volltextzugriff (PDF)

907. The HCV Care Continuum Among Hospitalized Persons Who Inject Opiates: Missed Opportunities for Screening and Referral to Treatment

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S545-S545

2021

Volltextzugriff (PDF)

844. High Risk Behaviors, Suboptimal HIV Viral Suppression, and Limited PrEP Use among People Who Engage in Transactional Sex

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S512-S513

2021

Volltextzugriff (PDF)

859. Suboptimal Uptake, Retention, and Adherence of Daily Oral PrEP Among People with OUD Receiving HCV Treatment

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S520-S521

2021

Volltextzugriff (PDF)

1297. Characteristics for PrEP Uptake, Retention, and Discontinuation: Data From the ANCHOR Study

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S396-S396

2018

Volltextzugriff (PDF)

2897. Collocated Buprenorphine Is Associated with Improved HCV Visit Adherence in People Who Inject Drugs (PWID): Data From the ANCHOR Study

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S82-S82

2019

Volltextzugriff (PDF)

2900. High Rates of Experienced and Witnessed Opioid Overdose in PWID Receiving HCV Treatment: Data From the ANCHOR Study

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S83-S83

2019

Volltextzugriff (PDF)

Longterm Evaluation of Hemoglobin A1c Following Hepatitis C Therapy in Patients with and without HIV Co-infection

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S657-S658

2017

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hepatitis C virus (HCV)-specific T cell confer resistance to HCV re-infection after sustained virologic response in a non-cytolytic fashion among people who inject drugs: results from ANCHOR study

Long-term outcomes associated with task-shifting of HCV treatment by non-specialist providers: five year follow-up from the ASCEND cohort

Diabetes Mellitus Type II and Abnormal Glucose Metabolism in the setting of HIV

Association of sustained virologic response with measures of direct-acting antiviral adherence in patients with Hepatitis C: data from the ASCEND and ANCHOR investigations

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus: HIV and Endocrine Disorders

Expansion of Treatment for Hepatitis C Virus Infection

HCV reinfection associated with IDU and cocaine use in a cohort of people with OUD: 4 Year follow-up data from the ANCHOR cohort

100. "They Never Asked Me": A Mixed-Methods Study to Evaluate the INJECT-RESPECT Tool for Assessing Infectious and Non-Infectious risks of Injection Drug Use

Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial

Use of Non-Stigmatizing Language is Associated with Improved Outcomes in Hospitalized People Who Inject Drugs

298. Collocation of Hepatitis C Care Continuum with MAT for High-Prevalence, High-Risk Population

2061. High Rates of Viremic HIV, Risky Sexual Behaviors, and Interest in Gender Affirming Hormone Therapy among Transgender Individuals Who Engage in Transactional Sex

799. Unstable Housing, Daily Drug Use, and Transactional Sex are Associated with Viremia in Transgender Individuals Living with HIV

1362. Adding Insult to Injury: Association of Stigmatizing Language and Suboptimal Outcomes in People Who Inject Drugs

611. No Source Control: Low Rates of Medication for Opioid Use Disorder in Individuals Hospitalized with Infectious Complications of Injection Opioid Use at Four Academic Medical Centers

907. The HCV Care Continuum Among Hospitalized Persons Who Inject Opiates: Missed Opportunities for Screening and Referral to Treatment

844. High Risk Behaviors, Suboptimal HIV Viral Suppression, and Limited PrEP Use among People Who Engage in Transactional Sex

859. Suboptimal Uptake, Retention, and Adherence of Daily Oral PrEP Among People with OUD Receiving HCV Treatment

1297. Characteristics for PrEP Uptake, Retention, and Discontinuation: Data From the ANCHOR Study

2897. Collocated Buprenorphine Is Associated with Improved HCV Visit Adherence in People Who Inject Drugs (PWID): Data From the ANCHOR Study

2900. High Rates of Experienced and Witnessed Opioid Overdose in PWID Receiving HCV Treatment: Data From the ANCHOR Study

Longterm Evaluation of Hemoglobin A1c Following Hepatitis C Therapy in Patients with and without HIV Co-infection

Aktive Filter

Suchergebnisse filtern